Successful therapy with mycophenolic acid in a membranous glomerulonephritis due to Kimura disease
.

Détails

ID Serval
serval:BIB_8C4C901DA823
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Titre
Successful therapy with mycophenolic acid in a membranous glomerulonephritis due to Kimura disease
.
Périodique
Clinical nephrology
Auteur(s)
Gaillard J., Rotman S., Girardet C., Spertini F.
ISSN
0301-0430 (Print)
ISSN-L
0301-0430
Statut éditorial
Publié
Date de publication
10/2017
Peer-reviewed
Oui
Volume
88
Numéro
10
Pages
221-225
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Kimura disease (KD) is a rare inflammatory soft tissue disorder of unknown origin most frequent in Asians, the prevalence of which is growing in Western countries. Painless papules and/or nodules with a predilection for the head and the neck region, lymphadenopathies, parotid gland involvement, eosinophilia, and raised IgE levels are parts of its presentation. Renal involvement with various forms of glomerulonephritis, including membranous nephropathy (MN), can occur and is generally associated with a proteinuria that encompasses nephrotic syndrome. Corticosteroids are the mainstay of treatment of KD-associated glomerulonephritis, but steroids withdrawal is often followed by relapsing nephrotic syndrome. Various immunosuppressive agents have been tested to prolong the remission of KD-associated nephrotic syndrome while tapering steroids, but they are only partly effective or associated with significant complications. To the best of our knowledge, we describe here the first case of KD-related membranous glomerulonephritis with a favorable evolution and a sustained remission of 4 years under prolonged therapy with mycophenolic acid (MPA). MPA and its active metabolite, mycophenolate mofetil (MMF), treatments as supportive therapies to corticosteroids and ACE inhibitors should be further investigated in KD-related membranous nephropathies.
.

Pubmed
Web of science
Création de la notice
01/09/2017 9:18
Dernière modification de la notice
20/08/2019 15:50
Données d'usage